作者:
Adam E,Frampton [1]
;
Leandro,Castellano [2]
;
Teresa,Colombo [3]
;
Elisa,Giovannetti [4]
;
Jonathan,Krell [5]
;
Jimmy,Jacob [5]
;
Loredana,Pellegrino [5]
;
Laura,Roca-Alonso [5]
;
Niccola,Funel [6]
;
Tamara M H,Gall [2]
;
Raida,Ahmad [7]
;
Nagy A,Habib [2]
;
Thomas,Knösel [8]
;
Justin,Stebbing [5]
;
Long R,Jiao [2]
作者单位:
HPB Surgical Unit, Department of Surgery and Cancer, Imperial College, Hammersmith Hospital Campus, London, UK. Electronic address: a.frampton@imperial.ac.uk.
[1]
HPB Surgical Unit, Department of Surgery and Cancer, Imperial College, Hammersmith Hospital Campus, London, UK.
[2]
Department of Cellular Biotechnology and Haematology, La Sapienza University, Rome, Italy.
[3]
Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands.
[4]
Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital Campus, London, UK.
[5]
Experimental and Molecular Oncology, Department of Surgery, University of Pisa, Pisa, Italy.
[6]
Centre for Pathology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
[7]
Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany.
[8]
DOI
10.1016/S0140-6736(15)60352-X
PMID
26312859
发布时间
2024-02-10